BIIB vs SEIC · P/E 21, rev $9.89B vs P/E 16, rev $1.26B
Biogen Inc (BIIB) versus SEI Investments Company (SEIC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
SEI Investments Company (SEIC) is a asset management company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SEIC revenue for 2026-06-30 was $1.26B. Net income was $370.1M. SEIC currently screens at market cap $10.95B and trailing P/E 15.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SEIC currently screens at market cap $10.95B and trailing P/E 15.5.
Not investment advice. Open the BIIB and SEIC stock pages for the full models.
Not investment advice.